The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans

A better understanding of tumor metastasis requires development of animal models that authentically reproduce the metastatic process. By modifying an existing mouse model of breast cancer, we discovered that macrophage-stimulating protein promoted breast tumor growth and metastasis to several organs. A special feature of our findings was the occurrence of osteolytic bone metastases, which are prominent in human breast cancer. To explore the clinical relevance of our model, we examined expression levels of three genes involved in activation of the MSP signaling pathway (MSP, MT-SP1, and MST1R) in human breast tumors. We found that overexpression of MSP, MT-SP1, and MST1R was a strong independent indicator of both metastasis and death in human breast cancer patients and significantly increased the accuracy of an existing gene expression signature for poor prognosis. These data suggest that signaling initiated by MSP is an important contributor to metastasis of breast cancer and introduce an independent biomarker for assessing the prognosis of humans with breast cancer.

[1]  Zhiyuan Hu,et al.  Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay , 2006, Breast Cancer Research.

[2]  C. Craik,et al.  Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway , 2007, Proceedings of the National Academy of Sciences.

[3]  E. Leonard.  Biological aspects of macrophage-stimulating protein (MSP) and its receptor. , 1997, Ciba Foundation symposium.

[4]  Baljit Singh,et al.  Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. , 2003, Cancer research.

[5]  E. Leonard,et al.  Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. , 1996, Oncogene.

[6]  A. Iwama,et al.  Macrophage-stimulating protein activates STK receptor tyrosine kinase on osteoclasts and facilitates bone resorption by osteoclast-like cells. , 1996, Blood.

[7]  Ming-Hai Wang,et al.  Collaborative activities of macrophage-stimulating protein and transforming growth factor-β1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase , 2004, Oncogene.

[8]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[10]  M. Collins,et al.  Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. , 2005, Cancer research.

[11]  John N. Hutchinson,et al.  Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.

[12]  B. Peace,et al.  Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis , 2001, Oncogene.

[13]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[14]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[16]  Helen H. W. Chen,et al.  Prognostic Significance of Co-expression of RON and MET Receptors in Node-Negative Breast Cancer Patients , 2005, Clinical Cancer Research.

[17]  J. Pollard,et al.  Role of infiltrated leucocytes in tumour growth and spread , 2004, British Journal of Cancer.

[18]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[19]  Ming-Hai Wang,et al.  Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. , 2003, Carcinogenesis.

[20]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Ming-Hai Wang,et al.  Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo , 2002, Oncogene.

[22]  T. Pawson,et al.  Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein , 1999, Molecular and Cellular Biology.

[23]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[24]  E. Leonard,et al.  Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. , 1996, The Journal of clinical investigation.

[25]  S. J. Degen,et al.  Structure of the human D1F15S1A locus: a chromosome 1 locus with 97% identity to the chromosome 3 gene coding for hepatocyte growth factor-like protein. , 1998, DNA sequence : the journal of DNA sequencing and mapping.

[26]  P. Sismondi,et al.  Overexpression of the RON gene in human breast carcinoma , 1998, Oncogene.

[27]  Zena Werb,et al.  Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. , 2005, Molecular biology of the cell.

[28]  J. Pollard,et al.  Macrophages: modulators of breast cancer progression. , 2004, Novartis Foundation symposium.

[29]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[30]  P. Marchisio,et al.  The MSP Receptor Regulates α6β4 and α3β1 Integrins via 14-3-3 Proteins in Keratinocyte Migration , 2003 .

[31]  Jeffrey W Pollard,et al.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. , 2003, The American journal of pathology.

[32]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[33]  M. Lutz,et al.  Activation of CR3‐mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3‐kinase, and protein kinase C ζ , 2003, Journal of leukocyte biology.

[34]  R. Cardiff,et al.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. , 1994, Genes & development.

[35]  I. Bièche,et al.  Prognostic value of ERBB family mRNA expression in breast carcinomas , 2003, International journal of cancer.

[36]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[37]  A. Welm,et al.  MET and MYC cooperate in mammary tumorigenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.